SCHEMBL9609425

SCHEMBL9609425

O=c1c2ccccc2n(CCc2ccc(O)cc2)c2ccc([S+](c3ccc(F)cc3)c3ccc(F)cc3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 4/20 0.41
▸ HDAC1 Q13547 3/20 0.41
▸ HDAC11 Q96DB2 3/20 0.41
▸ HDAC8 Q9BY41 3/20 0.41
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ RXFP1 Q9HBX9 2/20 0.40
▸ GFER P55789 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NR4A2 P43354 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609423 0.90 P2RX4 (0.49) MAPTSMN1; SMN2ALDH1A1NPSR1KDM4E
SCHEMBL9609424 0.83 IDO1 (0.45) RXFP1ATMALDH1A1KDM4EGLA
SCHEMBL9609418 0.82 P2RX4 (0.47) RXFP1MAPTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL9609417 0.81 P2RX4 (0.61) MAPTSMN1; SMN2ALDH1A1MAPK1KDM4E
SCHEMBL9609400 0.80 ALDH1A1 (0.59) MAPTSMN1; SMN2ALDH1A1MAPK1NPSR1
SCHEMBL9609399 0.80 GLA (0.62) ALDH1A1KDM4EGLAPOLBHPGD
SCHEMBL9609428 0.79 ATM (0.62) MAPTATMALDH1A1GAAMAPK1
SCHEMBL9609395 0.79 HTT (0.48) MAPTATMALDH1A1GAAKDM4E
SCHEMBL9609419 0.77 P2RX4 (0.47) RXFP1MAPTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL9609413 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EPOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073854-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2015-07-07 — — US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 HDAC6 2381/4885HDAC1 978/4885HDAC11 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback